E2F1 Monoclonal antibody 66515-1-Ig proteintech

$149.00
In stock
SKU
66515-1-Ig
Catalog No.SizePrice (USD)
66515-1-IG-20UL20 μL$149.00
66515-1-IG-150UL150 μL$449.00
66515-1-IG-10X150UL1.5 mL (10 x 150 μL vials)$3,592.00
Catalog Number66515-1-Ig
Synonyms5D7G8, E2F 1, E2F-1, pRB-binding protein E2F-1, RBAP-1
HostMouse
Reactivityhuman, rat and More (1)
Reactivityhuman, rat, mouse
FormLiquid
FormulationPBS, Azide, Glycerol
ApplicationsWB, IHC, IF, IP, CoIP, ChIP, RIP, ELISA
ApplicationsWB, IP, ELISA
Host / IsotypeMouse / IgG2b
Tested Applications — Positive WB detected inLNCaP cells, HepG2 cells, HeLa cells, HEK-293 cells, Jurkat cells, HSC-T6 cells
Tested Applications — Positive IP detected inHEK-293T cells
Recommended Dilutions — Western Blot (WB)WB : 1:1000-1:6000
Recommended Dilutions — Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Positive WB detected inLNCaP cells, HepG2 cells, HeLa cells, HEK-293 cells, Jurkat cells, HSC-T6 cells
Positive IP detected inHEK-293T cells
Western Blot (WB)WB : 1:1000-1:6000
Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Tested Reactivityhuman, rat
Cited Reactivityhuman, mouse, rat
ClassMonoclonal
TypeAntibody
ImmunogenCatNo: Ag17363 Product name: Recombinant human E2F1 protein Source: e coli. -derived, PET28a Tag: 6*His Domain: 88-438 aa of BC050369 Sequence: VKRRLDLETDHQYLAESSGPARGRGRHPGKGVKSPGEKSRYETSLNLTTKRFLELLSHSADGVVDLNWAAEVLKVQKRRIYDITNVLEGIQLIAKKSKNHIQWLGSHTTVGVGGRLEGLTQDLRQLQESEQQLDHLMNICTTQLRLLSEDTDSQRLAYVTCQDLRSIADPAEQMVMVIKAPPETQLQAVDSSENFQISLKSKQGPIDVFLCPEETVGGISPGKTPSQEVTSEEENRATDSATIVSPPPSSPPSSLTTDPSQSLLSLEQEPLLSRMGSLRAPVDEDRLSPLVAADSLLEHVREDFSGLLPEEFISLSPPHEALDYHFGLEEGEGIRDLFDCDFGDLTPLDF Predict reactive species
Full NameE2F transcription factor 1
Calculated Molecular Weight437 aa, 47 kDa
Observed Molecular Weight55-60 kDa
GenBank Accession NumberBC050369
Gene SymbolE2F1
Gene ID (NCBI)1869
RRIDAB_2881878
ConjugateUnconjugated
Purification MethodProtein A purification
UNIPROT IDQ01094
Storage BufferPBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20 o C storage. 20ul sizes contain 0.1% BSA.
IP protocol for E2F1 antibody 66515-1-IgDownload protocol
WB protocol for E2F1 antibody 66515-1-IgDownload protocol
humanWB Cell Rep FAK-mediated phosphorylation at Y464 regulates p85β nuclear translocation to promote tumorigenesis of ccRCC by repressing RB1 expression Authors - Yanhua Zhang View Article
mouseWB J Adv Res Transducin-like enhancer of split 3 protects against lipopolysaccharide-induced inflammation through DDX5-ATF1-PPP2R5A signaling Authors - Di Fan View Article
Umut (Verified Customer) (08-30-2023)It works very well, even though it is diluted a lot, i.e., 1:2000. The total protein concentration of my samples were around 2 ug/ml before adding 1:4 laemmli buffer and denature, and it is able to capture the target at low exposure times. Applications: Western Blot Primary Antibody Dilution: 1:2000 Cell Tissue Type: U87MG, glioma-derived E2F1 Antibody Western Blot validation (1:2000 dilution) in U87MG, glioma-derived (Cat no:66515-1-Ig)
Juliane (Verified Customer) (05-11-2023)The antibody worked fine, but only under using ECL sensitve reagent and high exposure when imaging. Applications: Western Blot Primary Antibody Dilution: 1:1000 Cell Tissue Type: HEK293T E2F1 Antibody Western Blot validation (1:1000 dilution) in HEK293T (Cat no:66515-1-Ig)
Citations101
DilutionsWB : 1:1000-1:6000 IP : 0.5-4.0 ug for IP and 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate for WB
IsotypeIgG2b
ClonalityMonoclonal
Clone Number5D7G8
ConjugationUnconjugated

Transcription factor E2F1 (E2F1), also known as RBBP3, is a transcription activator that binds DNA cooperatively with dp proteins through the E2 recognition site, 5'-TTTC[CG]CGC-3' found in the promoter region of a number of genes whose products are involved in cell cycle regulation or in DNA replication. The DRTF1/E2F complex functions in the control of cell-cycle progression from G1 to S phase. E2F-1 binds preferentially RB1 protein, in a cell-cycle dependent manner. It can mediate both cell proliferation and p53-dependent apoptosis. The calculated molecular weight of E2F1 is 47 kDa, but the sumoylated E2F1 is bout 55-60 kDa. Protocols Product Specific Protocols IP protocol for E2F1 antibody 66515-1-Ig Download protocol WB protocol for E2F1 antibody 66515-1-Ig Download protocol Standard Protocols Click here to view our Standard Protocols

Publications

  1. Mitochondrial CCN1 drives ferroptosis via fatty acid β-oxidation
    Journal: Dev Cell | Authors: Wanxin Guo | Species: human | Application: WB
  2. LncRNA AGPG confers endocrine resistance in breast cancer by promoting E2F1 activity
    Journal: Cancer Res | Authors: Shiyi Yu | Species: human | Application: WB,IF
  3. Transducin-like enhancer of split 3 protects against lipopolysaccharide-induced inflammation through DDX5-ATF1-PPP2R5A signaling
    Journal: J Adv Res | Authors: Di Fan | Species: mouse | Application: WB
  4. ZNF652 exerts a tumor suppressor role in lung cancer by transcriptionally downregulating cyclin D3
    Journal: Cell Death Dis | Authors: Chunfeng Xie | Species: human | Application: WB
  5. Identification of STAM-binding protein as a target for the treatment of gemcitabine resistance pancreatic cancer in a nutrient-poor microenvironment
    Journal: Cell Death Dis | Authors: Wenming Zhang KD Validated | Species: human | Application: WB,IHC,IF,CoIP
  6. FAK-mediated phosphorylation at Y464 regulates p85β nuclear translocation to promote tumorigenesis of ccRCC by repressing RB1 expression
    Journal: Cell Rep | Authors: Yanhua Zhang | Species: human | Application: WB
  7. MYC induces CDK4/6 inhibitors resistance by promoting pRB1 degradation
    Journal: Nat Commun | Authors: Jian Ma | Species: human | Application: WB
  8. RNA m5C modification upregulates E2F1 expression in a manner dependent on YBX1 phase separation and promotes tumor progression in ovarian cancer
    Journal: Exp Mol Med | Authors: Xiaoyi Liu | Species: human | Application: WB
  9. Transducin-like enhancer of split 3 protects against lipopolysaccharide-induced inflammation through DDX5-ATF1-PPP2R5A signaling
    Journal: J Adv Res | Authors: Di Fan | Species: mouse | Application: WB
  10. Inhibition of METTL14 overcomes CDK4/6 inhibitor resistance driven by METTL14-m6A-E2F1-axis in ERα-positive breast cancer
    Journal: J Nanobiotechnology | Authors: Chenlin Liu | Species: human | Application: WB
  11. Druggable target ATAD2 enhances the malignant progression and cooperates with E2F1 to up-regulate PDK1 expression in glioma.
    Journal: Genes Dis | Authors: Shenghua Zhuo | Species: human | Application: IHC
  12. Histone modification-regulated LncRNA DLEU1 interacts with ASCC2/ALKBH3 complex to drive DNA repair, antioxidant homeostasis and glucose metabolism in gastric cancer.
    Journal: Biomark Res | Authors: Xiaoyan Zhang | Species: human | Application: IHC
  13. E2F1-autophagy-ALDH1A1 axis enhances self-renewal and drug resistance of lung cancer stem-like cells in a p53-dependent manner
    Journal: J Exp Clin Cancer Res | Authors: Jingyuan Li | Application: WB
  14. The Compromised Fanconi Anemia Pathway in Prelamin A-Expressing Cells Contributes to Replication Stress-Induced Genomic Instability
    Journal: Adv Sci (Weinh) | Authors: Pengqing Nie | Species: human | Application: WB,IP
  15. Transferrin Receptor-Mediated Iron Uptake Promotes Colon Tumorigenesis
    Journal: Adv Sci (Weinh) | Authors: Hyeoncheol Kim | Species: human | Application: WB
  16. DDX5 super-enhancer promotes vasculogenic mimicry formation and metastasis in nasopharyngeal carcinoma by enhancing ADAM10 transcription
    Journal: Cell Rep Med | Authors: Tian Xia
  17. Engineered anchoring aptamers induce relocalization and functional inactivation of transcription factors.
    Journal: Sci Adv | Authors: Neng Ling | Species: human | Application: WB,IF
  18. GDPPH1 induces cell cycle arrest by downregulation of CDK4/Cyclin D1 via the m(6)A-METTL14-YTHDF2 axis, attenuating glioblastoma progression.
    Journal: Cell Death Dis | Authors: Sijia Li
  19. E2F1 mediated DDX11 transcriptional activation promotes hepatocellular carcinoma progression through PI3K/AKT/mTOR pathway.
    Journal: Cell Death Dis | Authors: Yan Yu | Species: human | Application: chIP
  20. Identification of STAM-binding protein as a target for the treatment of gemcitabine resistance pancreatic cancer in a nutrient-poor microenvironment
    Journal: Cell Death Dis | Authors: Wenming Zhang | Species: human | Application: WB,IHC,IF,CoIP
  21. CHAC1 blockade suppresses progression of lung adenocarcinoma by interfering with glucose metabolism via hijacking PKM2 nuclear translocation
    Journal: Cell Death Dis | Authors: Junfan Pan | Species: human | Application: WB,ChIP
  22. GDPPH1 induces cell cycle arrest by downregulation of CDK4/Cyclin D1 via the m(6)A-METTL14-YTHDF2 axis, attenuating glioblastoma progression.
    Journal: Cell Death Dis | Authors: Sijia Li
  23. Chicoric acid targets PYGL to normalize glycogenolysis-driven glycolysis to suppress non-small cell lung cancer.
    Journal: Cell Mol Biol Lett | Authors: Xingfa Huo
  24. SMEK1 promotes clear cell Renal Cell Carcinoma progression via EGFR tyrosine-kinase dependent pathway
    Journal: Cancer Lett | Authors: Jue Wang | Species: mouse,human | Application: WB,IHC,IF
  25. NEAT1 Promotes the Perineural Invasion of Pancreatic Cancer via the E2F1/GDNF Axis
    Journal: Cancer Lett | Authors: Jingtao Gu | Species: human | Application: WB,IHC
  26. Inhibition of IGF2BP1 attenuates renal injury and inflammation by alleviating m6A modifications and E2F1/MIF pathway
    Journal: Int J Biol Sci | Authors: Yan Mao | Application: ChIP
  27. Integrating network pharmacology deciphers the action mechanism of Zuojin capsule in suppressing colorectal cancer.
    Journal: Phytomedicine | Authors: Jin-Hua Fan | Species: human | Application: WB
  28. NCOA5 induces sorafenib resistance in hepatocellular carcinoma by inhibiting ferroptosis
    Journal: Cell Death Discov | Authors: Shuang Gao | Species: human | Application: WB
  29. Inhibition of USP10 induces myeloma cell apoptosis by promoting cyclin D3 degradation
    Journal: Acta Pharmacol Sin | Authors: Yu-Jia Xu | Species: human | Application: WB
  30. RRM1 promotes homologous recombination and radio/chemo-sensitivity via enhancing USP11 and E2F1-mediated RAD51AP1 transcription
    Journal: Cell Death Discov | Authors: Shuai Yang | Species: human | Application: WB,IP
  31. RRM1 promotes homologous recombination and radio/chemo-sensitivity via enhancing USP11 and E2F1-mediated RAD51AP1 transcription
    Journal: Cell Death Discov | Authors: Shuai Yang | Species: human | Application: WB,IP
  32. Overexpression of RACGAP1 by E2F1 Promotes Neuroendocrine Differentiation of Prostate Cancer by Stabilizing EZH2 Expression
    Journal: Aging Dis | Authors: Zhengshuai Song | Species: human | Application: WB,ChIP
  33. Mitochondrial CCN1 drives ferroptosis via fatty acid β-oxidation
    Journal: Dev Cell | Authors: Wanxin Guo | Species: human | Application: WB
  34. Oncogene goosecoid is transcriptionally regulated by E2F1 and correlates with disease progression in prostate cancer.
    Journal: Chin Med J (Engl) | Authors: Yue Ge | Species: human | Application: ChIP
  35. High-dose copper activates p53-independent apoptosis through the induction of nucleolar stress in human cell lines.
    Journal: Apoptosis | Authors: Chieh-Hsin Chen | Species: human | Application: WB
  36. In vivo CRISPR/Cas9-mediated screen reveals a critical function of TFDP1 and E2F4 transcription factors in hematopoiesis
    Journal: Leukemia | Authors: Ngoc Tung Tran | Species: mouse | Application: WB,IP
  37. LncRNA SNHG8 promotes myocardial fibrosis by binding to E2F1 to induce MAD2L1 transcription.
    Journal: Int J Biol Macromol | Authors: Lei Huang | Species: mouse, rat | Application: WB
  38. A novel recombinant peptide, rAnguillin, induces ferroptosis in nasopharyngeal carcinoma by promoting FOXM1 degradation and disrupting the FOXM1-PABPC1L-tryptophan metabolism axis.
    Journal: Int J Biol Macromol | Authors: Qianhui Yuan | Species: human | Application: WB
  39. Integrated network pharmacology and transcriptomic approach reveal the role of equol in reducing colorectal cancer via regulating multiple cell cycle genes in HCT116 cells
    Journal: Int J Biol Macromol | Authors: Kemin Mao | Species: human | Application: WB
  40. KDM1A, a potent and selective target, for the treatment of DNMT3A-deficient non-small cell lung cancer
    Journal: Br J Cancer | Authors: Yingxi Zhao | Species: human | Application: ChIP
  41. Restoration of NOX4 signalling reverses endothelial colony-forming cell angiogenic dysfunction associated with experimental and clinical diabetes
    Journal: Stem Cell Res Ther | Authors: Karla M O'Neill | Species: human | Application: WB
  42. FAK-mediated phosphorylation at Y464 regulates p85β nuclear translocation to promote tumorigenesis of ccRCC by repressing RB1 expression
    Journal: Cell Rep | Authors: Yanhua Zhang | Species: human | Application: WB
  43. Talaketides A-G, linear polyketides with prostate cancer cytotoxic activity from the mangrove sediment-derived fungus Talaromyces sp. SCSIO 41027
    Journal: Chin J Nat Med | Authors: Chunmei Chen | Species: human
  44. Deapioplatycodin D promotes cell senescence induced by P21 through the mediation of incomplete mitophagy via BNIP3L
    Journal: Biomed Pharmacother | Authors: Yiquan Li | Species: human | Application: WB
  45. NSUN2-mediated HCV RNA m5C Methylation Facilitates Viral RNA Stability and Replication
    Journal: Genomics Proteomics Bioinformatics | Authors: Zhu-Li Li | Species: human | Application: WB
  46. Interferon regulatory factor 4 mediates nonenzymatic IRE1 dependency in multiple myeloma cells
    Journal: PLoS Biol | Authors: Ioanna Oikonomidi | Species: human | Application: WB
  47. Arecoline as a Novel Scaffold Targeting the ATAD2 Bromodomain for Cell Cycle Modulation.
    Journal: Pharmaceutics | Authors: Ting-Syuan Lin | Species: human | Application: WB
  48. Classical prescription Floris Sophorae Powder treat colorectal cancer by regulating KRAS/MEK-ERK signaling pathway
    Journal: J Ethnopharmacol | Authors: Li-Ying Han | Species: mouse | Application: WB
  49. Classical prescription Floris Sophorae Powder treat colorectal cancer by regulating KRAS/MEK-ERK signaling pathway
    Journal: J Ethnopharmacol | Authors: Li-Ying Han | Species: mouse | Application: WB
  50. The influence of phenolic environmental estrogen on the transcriptome of uterine leiomyoma cells: A whole transcriptome profiling-based analysis.
    Journal: Ecotoxicol Environ Saf | Authors: Zemin Li | Species: human | Application: WB
  51. DLGAP5 upregulates E2F1 to promote prostate adenocarcinoma neuroendocrine differentiation
    Journal: Life Sci | Authors: Linghui Liang | Species: human | Application: WB
  52. E2F1 combined with LINC01004 super-enhancer to promote hepatocellular carcinoma cell proliferation and metastasis
    Journal: Clin Epigenetics | Authors: Jingxuan Li | Species: human | Application: WB,ChIP
  53. E2F1-mediated 53BP2 lactylation stabilizes p53 to induce cochlear hair cell apoptosis in mouse age-related hearing loss.
    Journal: Clin Epigenetics | Authors: Xiaoqin Luo | Species: mouse | Application: WB
  54. Deficiency of LAMP2A in macrophages accelerates hypoxia-induced atherosclerosis by inhibiting BNIP3-mediated mitophagy.
    Journal: Int Immunopharmacol | Authors: Ning Wang
  55. B3GNT3 facilitates NFKB2 processing and non-canonical NF-κB activation to drive lung adenocarcinoma progression.
    Journal: Cell Oncol (Dordr) | Authors: Ying Lin | Species: human | Application: WB
  56. Analysis of regulating activities of 5'-epiequisetin on proliferation, apoptosis, and migration of prostate cancer cells in vitro and in vivo
    Journal: Front Pharmacol | Authors: Xueni Wang | Species: human | Application: WB
  57. RFWD3 Participates in the Occurrence and Development of Colorectal Cancer via E2F1 Transcriptional Regulation of BIRC5.
    Journal: Front Cell Dev Biol | Authors: Fenghua Xu | Species: human | Application: IP,ChIP
  58. MASTL Promotes Hepatocellular Carcinoma Progression and Paclitaxel Resistance Through Mitotic Catastrophe.
    Journal: Cancer Sci | Authors: Ke Wang | Species: human | Application: WB,ChIP
  59. ARL8B regulates lysosomal function and predicts poor prognosis in hepatocellular carcinoma
    Journal: Sci Rep | Authors: Liyan Wu | Species: human | Application: WB
  60. NCAPD2 promotes breast cancer progression through E2F1 transcriptional regulation of CDK1
    Journal: Cancer Sci | Authors: Jinsong He | Species: human | Application: CoIP
  61. MASTL Promotes Hepatocellular Carcinoma Progression and Paclitaxel Resistance Through Mitotic Catastrophe.
    Journal: Cancer Sci | Authors: Ke Wang | Species: human | Application: WB,ChIP
  62. Cell division cycle associated 8: A novel diagnostic and prognostic biomarker for hepatocellular carcinoma
    Journal: J Cell Mol Med | Authors: Xiao-Han Cui | Species: human | Application: WB
  63. TIFA enhances glycolysis through E2F1 and promotes the progression of glioma
    Journal: Cell Signal | Authors: Zhibing Liu | Species: human | Application: WB
  64. UCA1 facilitates endometriosis progression through EIF4A3-mediated stabilization of E2F1 mRNA and enhanced glycolysis.
    Journal: Cell Signal | Authors: Yingying Cao | Species: human | Application: RIP
  65. TRIB3 promotes endometrial cancer progression through interacting with E2F1 and enhancing PKM2-mediated tumor glycolysis
    Journal: Gynecol Oncol | Authors: Feng Geng | Application: IF,ChIP
  66. Teriflunomide/leflunomide synergize with chemotherapeutics by decreasing mitochondrial fragmentation via DRP1 in SCLC
    Journal: iScience | Authors: Tamara Mirzapoiazova | Species: human | Application: WB
  67. Icaritin inhibits CDK2 expression and activity to interfere with tumor progression
    Journal: iScience | Authors: Chao Zhang | Species: human | Application: WB,CoIP
  68. DDB2 promotes melanoma cell growth by transcriptionally regulating the expression of KMT2A and predicts a poor prognosis
    Journal: FASEB J | Authors: Changlin Zhang | Species: human | Application: WB
  69. Myricanol Inhibits Platelet Derived Growth Factor-BB-Induced Vascular Smooth Muscle Cells Proliferation and Migration in vitro and Intimal Hyperplasia in vivo by Targeting the Platelet-Derived Growth Factor Receptor-β and NF-κB Signaling.
    Journal: Front Physiol | Authors: Siyuan Fan | Species: rat | Application: WB
  70. TUBA1C: a new potential target of LncRNA EGFR-AS1 promotes gastric cancer progression
    Journal: BMC Cancer | Authors: Haodong Wang | Species: human | Application: WB
  71. Ubiquitin-specific peptidase 14 maintains estrogen receptor α stability via its deubiquitination activity in endometrial cancer
    Journal: J Biol Chem | Authors: Yingjie Su | Species: human | Application: WB
  72. The acidic microenvironment promotes pancreatic cancer progression via the lncRNA-LOC100507424/E2F1/FOXM1 axis
    Journal: BMC Cancer | Authors: Deyang Mu | Application: WB
  73. A novel piperine derivative HJ-23 exhibits anti-colorectal cancer effects by activating the p53 pathway
    Journal: Naunyn Schmiedebergs Arch Pharmacol | Authors: Meiqi Zhang | Species: human | Application: WB
  74. NCAPH Promotes the Proliferation of Prostate Cancer Cells Via Modulating the E2F1 Mediated PI3K/AKT/mTOR Axis
    Journal: Int J Med Sci | Authors: Qing Shi | Species: human | Application: CoIP,ChIP
  75. KLF11 interacts with MDM2 to stabilize E2F1 and promotes DNA damage repair to induce radioresistance in esophageal cancer cells.
    Journal: Pathol Res Pract | Authors: Yaoxiong Xia | Species: human | Application: WB,IHC,IF,CoIP
  76. E2F1-Driven WDHD1 Transcription Enhances Cell-Cycle Progression and Promotes Pancreatic Cancer Progression.
    Journal: Curr Oncol | Authors: Xiaojuan Yang | Species: human | Application: ChIP
  77. LncRNA LINC01703 promotes the proliferation, migration, and invasion of colorectal cancer by activating PI3K/AKT pathway
    Journal: J Biochem Mol Toxicol | Authors: Yuanhui Xu | Species: human | Application: WB
  78. NAT10 and E2F1 Orchestrate CKAP5-Mediated Progression in Esophageal Squamous Cell Carcinoma.
    Journal: J Gastroenterol Hepatol | Authors: Wenxue Wei | Species: human | Application: ChIP
  79. NAT10 and E2F1 Orchestrate CKAP5-Mediated Progression in Esophageal Squamous Cell Carcinoma.
    Journal: J Gastroenterol Hepatol | Authors: Wenxue Wei | Species: human | Application: ChIP
  80. FOXO1 inhibits prostate cancer cell proliferation via suppressing E2F1 activated NPRL2 expression
    Journal: Cell Biol Int | Authors: Yu Tang | Species: human | Application: WB,IF,ChIP
  81. Thymidine Kinase 1 Drives Skin Cutaneous Melanoma Malignant Progression and Metabolic Reprogramming.
    Journal: Front Oncol | Authors: Sipeng Zuo | Species: human | Application: WB
  82. FGF14-AS2 accelerates tumorigenesis in glioma by forming a feedback loop with miR-320a/E2F1 axis.
    Journal: J Cancer | Authors: Peng Zhang | Species: human | Application: WB
  83. POLD2 is activated by E2F1 to promote triple-negative breast cancer proliferation
    Journal: Front Oncol | Authors: Zhen Zhang | Species: human | Application: WB,ChIP
  84. CDCA4/SERTAD1/E2F1 Facilitates Lung Adenocarcinoma Progression by Inhibiting PINK1/Parkin-Mediated Mitophagy.
    Journal: IUBMB Life | Authors: Jianlong Tan | Species: human | Application: WB
  85. GPC3 Promotes Lung Squamous Cell Carcinoma Progression and HLA-A2-Restricted GPC3 Antigenic Peptide-Modified Dendritic Cell-Induced Cytotoxic T Lymphocytes to Kill Lung Squamous Cell Carcinoma Cells
    Journal: J Immunol Res | Authors: Jing Ning | Species: human | Application: WB
  86. E2F1-mediated GINS2 transcriptional activation promotes tumor progression through PI3K/AKT/mTOR pathway in hepatocellular carcinoma
    Journal: Am J Cancer Res | Authors: Yao Zhang | Species: human | Application: WB
  87. Long non-coding RNA SNHG1 activates glycolysis to promote hepatocellular cancer progression through the miR-326/PKM2 axis.
    Journal: J Gene Med | Authors: Yue Wang | Species: human | Application: ChIP
  88. Downregulation of lncRNA HCG11 promotes cell proliferation of oral squamous cell carcinoma through sponging miR-455-5p.
    Journal: J Gene Med | Authors: Jingjing Wu | Species: human | Application: WB
  89. TRIM28 recruits E2F1 to regulate CBX8-mediated cell proliferation and tumor metastasis of ovarian cancer
    Journal: Hum Cell | Authors: Fubin Zhang | Species: human | Application: WB,IHC
  90. P129, a pyrazole ring-containing isolongifolanone-derivate: synthesis and investigation of anti-glioma action mechanism
    Journal: Discov Oncol | Authors: Yining Jiang
  91. Augmentation of the therapeutic efficacy of WEE1 kinase inhibitor AZD1775 by inhibiting the YAP-E2F1-DNA damage response pathway axis.
    Journal: FEBS Open Bio | Authors: Yusuke Oku | Species: human | Application: WB
  92. N-Acetyl-L-Cysteine Reduces Cervical Carcinogenesis by Promoting Apoptosis
    Journal: Drugs R D | Authors: Wenping Guo | Species: human | Application: WB
  93. siRNA Delivery for Control of Cyclin D1 and E2F1 Expression in Crohn's Disease.
    Journal: Transl Med UniSa | Authors: Ilaria Russo | Species: human | Application: IHC
  94. MicroRNA miR-188-5p as a mediator of long non-coding RNA MALAT1 regulates cell proliferation and apoptosis in multiple myeloma
    Journal: Bioengineered | Authors: Hui Liu | Species: human | Application: WB
  95. U2 small nuclear RNA auxiliary factor 2, transcriptionally activated by the transcription factor Dp-1/E2F transcription factor 1 complex, enhances the growth and aerobic glycolysis of leiomyosarcoma cells
    Journal: Bioengineered | Authors: Yuguo Li | Species: human | Application: ChIP
  96. Inhibition of Angiogenesis by MiR-524-5p through Suppression of AKT and ERK Activation by Targeting CXCR7 in Colon Cancer Cells
    Journal: J Oncol | Authors: Xiang Li | Species: human | Application: WB
  97. E2F-mediated POLA2 upregulation is correlated with macrophage infiltration and poor prognosis in hepatocellular carcinoma
    Journal: Transl Cancer Res | Authors: Yao Teng | Species: human | Application: WB
  98. HPV16 E7 Enhances Cell Stemness via RTKN2-Mediated Activation of the NF-κB Pathway in Cervical Cancer
    Journal: Biochem Genet | Authors: Min Yang | Application: WB
  99. Deletion of p16 accelerates fracture healing in geriatric mice.
    Journal: Am J Transl Res | Authors: Qirui Ding | Species: human | Application: WB
  100. Regular exercise suppresses steatosis-associated liver cancer development by degrading E2F1 and c-Myc via circadian gene upregulation
    Journal: Genes Cells | Authors: Vu Thuong Huyen | Species: mouse | Application: WB
  101. siRNA Delivery for Control of Cyclin D1 and E2F1 Expression in Crohn's Disease.
    Journal: Transl Med UniSa | Authors: Ilaria Russo | Species: human | Application: IHC
  102. DHCR24(+) tumor epithelial cells drive cisplatin resistance in bladder cancer by enhancing cholesterol metabolism to activate lipid raft-associated MAPK signaling.
    Journal: Oncogene | Authors: Yuanqiao Zhao | Species: human | Application: WB

Product Documents

Datasheet

Datasheet

Reviews

Write Your Own Review
You're reviewing:E2F1 Monoclonal antibody 66515-1-Ig proteintech
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.